Conveners
Industrial Session
- Tal Yehiel
Description
Sponsors:
- CollPlant
- Polbionica
- BioCloner Health
- BIOinx
- BIO3DPrinting
-
Shirel Cohen (Collplant)16/09/2025, 13:30podium presentation
rhCollagen Bioinks for Biofabrication
Cohen S.; Noor N.; Seror J.; Olami H.; Braiman U. Grienberg R. Ioffe K; Buravenkov V. and
Gazal E.
CollPlant Biotechnologies Ltd., 4 Oppenheimer St, Rehovot, IsraelIntroduction
Bioinks are a cornerstone of 3D bioprinting, providing the essential biological and mechanical framework required for the precise deposition of living cells, biomaterials,...
Go to contribution page -
Maciej Szurek (Polbionica S.A.)16/09/2025, 14:00podium presentation
Biomaterials and Bioreactor with ISO 13485 Standards โ Reliable Tools for Everyday Research.
Go to contribution page
One of the biggest challenges in organoid and tissue engineering research is reproducibility. Small changes in bioinks composition or inconsistent bioreactor settings often lead to different results, even when protocols are similar. This slows down projects and makes it hard to compare data across... -
Maciej Tabiszewski (BioCloner Health)16/09/2025, 14:15podium presentation
The rapid evolution of biomedical technologies is transforming both research and clinical practice, creating new opportunities to improve both human and animal health. BioCloner Health develops a multifunctional system for biofabrication that integrates tools, platforms, and processes to bridge the gap between scientific discovery and practical application. The focus is on purposeful...
Go to contribution page -
Aysu Arslan (BIO INX BV)16/09/2025, 14:30podium presentation
Bioprinting has rapidly advanced into a key enabling technology for biomedical research, offering unique capabilities to fabricate complex biological architectures with high precision and adaptability. Its versatility spans a wide range of resolutions, making it possible to construct both large-scale scaffolds and finely detailed microstructures. Central to the success of this approach is the...
Go to contribution page -
Ginevra Pegollo (Bio3DPrinting)16/09/2025, 14:40podium presentation
Bioprinting has made remarkable progress in the fabrication of functional tissues and organ constructs, ushering in a new era of personalized medicine with applications in transplantation, drug testing, research, and disease modeling. Bio3DPrinting has taken a significant step towards clinical translation by introducing Electrospider, a bioprinting ecosystem engineered for versatile multiscale...
Go to contribution page